Palantir Technologies Valuation
Is PTX undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PTX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PTX (€59.85) is trading above our estimate of fair value (€35.95)
Significantly Below Fair Value: PTX is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PTX?
Key metric: As PTX barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is PTX's PB Ratio? | |
|---|---|
| PB Ratio | 32.6x |
| Book | US$4.50b |
| Market Cap | US$146.59b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 53.8x |
| Enterprise Value/EBITDA | 358x |
| PEG Ratio | 13.2x |
Price to Book Ratio vs Peers
How does PTX's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 39x | ||
INTU Intuit | 9.9x | 17.6% | US$179.3b |
APP AppLovin | 119.2x | 30.1% | US$111.9b |
ADBE Adobe | 15.5x | 16.5% | US$225.4b |
SNPS Synopsys | 11.3x | 12.7% | US$86.8b |
PTX Palantir Technologies | 32.6x | 23.3% | €146.6b |
Price-To-Book vs Peers: PTX is good value based on its Price-To-Book Ratio (32.6x) compared to the peer average (39x).
Price to Book Ratio vs Industry
How does PTX's PB Ratio compare vs other companies in the European Software Industry?
| 32 Companies | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
| 32 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Book vs Industry: PTX is expensive based on its Price-To-Book Ratio (32.6x) compared to the European Software industry average (2.7x).
Price to Book Ratio vs Fair Ratio
What is PTX's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 32.6x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate PTX's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | €35.10 0% | 34.9% | €53.80 | €10.38 | n/a | 16 |
| Nov ’25 | n/a | €25.96 0% | 37.0% | €46.03 | €8.28 | n/a | 17 |
| Oct ’25 | n/a | €23.98 0% | 37.7% | €44.93 | €8.09 | n/a | 16 |
| Sep ’25 | n/a | €22.78 0% | 28.1% | €34.22 | €8.10 | n/a | 17 |
| Aug ’25 | €25.12 | €21.39 -14.8% | 27.6% | €32.38 | €8.33 | n/a | 16 |
| Jul ’25 | n/a | €19.99 0% | 30.6% | €32.67 | €8.40 | n/a | 17 |
| Jun ’25 | €19.69 | €19.94 +1.2% | 31.4% | €32.45 | €8.34 | n/a | 16 |
| May ’25 | €21.32 | €19.06 -10.6% | 33.4% | €32.88 | €4.70 | n/a | 18 |
| Apr ’25 | n/a | €18.64 0% | 33.4% | €32.59 | €4.66 | n/a | 18 |
| Mar ’25 | n/a | €17.32 0% | 30.8% | €27.89 | €4.65 | n/a | 16 |
| Feb ’25 | n/a | €14.40 0% | 35.6% | €23.14 | €4.63 | n/a | 16 |
| Jan ’25 | n/a | €14.24 0% | 35.0% | €22.79 | €4.56 | n/a | 16 |
| Dec ’24 | n/a | €14.24 0% | 35.0% | €22.79 | €4.56 | n/a | 16 |
| Nov ’24 | n/a | €13.18 0% | 37.3% | €23.66 | €4.73 | n/a | 16 |
| Oct ’24 | n/a | €13.33 0% | 37.7% | €23.61 | €4.72 | n/a | 16 |
| Sep ’24 | n/a | €12.81 0% | 39.3% | €23.04 | €4.61 | n/a | 15 |
| Aug ’24 | n/a | €10.80 0% | 48.2% | €22.76 | €4.55 | €25.12 | 14 |
| Jul ’24 | n/a | €9.30 0% | 41.9% | €16.49 | €4.58 | n/a | 13 |
| Jun ’24 | €13.53 | €8.27 -38.9% | 29.4% | €14.04 | €4.68 | €19.69 | 14 |
| May ’24 | n/a | €8.02 0% | 31.2% | €13.75 | €4.58 | €21.32 | 15 |
| Apr ’24 | n/a | €8.25 0% | 32.3% | €14.18 | €4.73 | n/a | 14 |
| Mar ’24 | n/a | €8.25 0% | 32.3% | €14.18 | €4.73 | n/a | 14 |
| Feb ’24 | n/a | €7.76 0% | 37.4% | €13.80 | €4.14 | n/a | 13 |
| Jan ’24 | n/a | €8.61 0% | 37.1% | €14.14 | €4.24 | n/a | 12 |
| Dec ’23 | €6.99 | €9.40 +34.6% | 32.8% | €14.49 | €4.83 | n/a | 11 |
| Nov ’23 | n/a | €10.69 0% | 35.6% | €20.25 | €6.07 | n/a | 11 |
Analyst Forecast: Target price is lower than the current share price.